Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»ó¾Ç¿¡ ½Ä¸³µÈ Frialit-2 ÀÓÇöõÆ®ÀÇ ¼º°ø·ü¿¡ ´ëÇÑ ÈÄÇâÀû ¿¬±¸

Retrospective analysis of frialit-2(R) implant system placed in maxilla

´ëÇÑÄ¡ÁÖ°úÇÐȸÁö 2005³â 35±Ç 2È£ p.449 ~ 460
¼Ò¼Ó »ó¼¼Á¤º¸
ä°æÁØ Á¤ÀÇ¿ø/±è⼺/½ÉÁؼº/Á¶±Ô¼º/±èÁ¾°ü/ÃÖ¼ºÈ£

Abstract


Objectives
Aim of this study was to evaluate the clinical use and the efficacy of Frialit-2 implant
system.
Experimental Methods
Fifty nine patients received placement of Frilalit-2 implants(137 implants) in their maxillary
anterior and posterior sites(40 and 97 implants). Intraoral & clinical examination, chart review
and radiographs were taken from each patient.
Results
1. The total implant survival rate was 92.7% after a mean follow-up period of 19.9
months.
2. The implant survival rate placed in anterior region was 97.5%.
3. The implant survival rate placed in posterior region was 90.7%.
4. The implant survival rate placed in atrophic posterior maxilla with advanced technique
(GBR, Sinus elevation) was 87.2%.
5. The implant survival rate placed in type ¥³(D4) bone was 82%, while 95.7% in type ¥²(D3), and 100% in type ¥±(D2) bone.
6. Most of the failed implants(7 of 10) were removed during the maintenance stage after
prosthodontic treatment.
Conclusion34)
It was concluded that Frialit-2 implant could be used satisfactorily in the esthetic anterior
region, but the use in the posterior region, especially with poor bone quality and quantity,
further studies are needed.

Å°¿öµå

Implant;Frialit-2 implant;Bone type

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI